Fan Chengzhong, Hernandez-Pampaloni Miguel, Houseni Mohamed, Chamroonrat Wichana, Basu Sandip, Kumar Rakesh, Dadparvar Simin, Torigian Drew A, Alavi Abass
Division of Nuclear Medicine, Hospital of University of Pennsylvania, Philadelphia, PA, USA.
Mol Imaging Biol. 2007 Sep-Oct;9(5):300-7. doi: 10.1007/s11307-007-0100-9.
The objective of the study was to determine age-related changes occurring in red marrow with regard to its distribution and the degree of its metabolic activity by whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG)-positron emission tomography (PET).
This retrospective study included 112 patients (56 male, 56 female, mean age 40 years, range 2-85) who underwent whole-body FDG-PET scans for assessment of disorders that were determined not to affect red marrow activity. These patients were categorized into the following groups with equal gender distribution: 0-15 years (12 individuals), 16-25 years (20), 26-35 years (10), 36-45 years (20), 46-55 years (14), 56-65 years (16), 66-75 years (14), and 76-85 years (6). Whole-body FDG-PET images were performed at 60 min after the intravenous administration of 0.14 mCi/kg of FDG. By employing a dedicated whole-body PET scanner. Maximal standardized uptake value (SUV(max)) was calculated from three consecutive transverse sections of the upper thirds of the humeri and femora, manubrium of the sternum, 12th thoracic and 5th lumbar vertebra and anterior superior iliac crests of the pelvis. All available results from other imaging examinations [magnetic resonance imaging (MRI), computed tomography (CT), and conventional radiolography], laboratory data, biopsies, and the clinical course of these subjects were reviewed to make certain that the bone marrow sites examined were free of any known pathologies.
SUV(max) in the extremities showed significant decline with aging (correlation coefficient of -0.60 to -0.67, p < 0.01). In contrast, a weak correlation was noted in the axial skeletal activity with advancing age (correlation coefficient of -0.28 to -0.48, p < 0.05).
These data suggest that FDG metabolic activity of the red marrow in the extremities decline significantly with normal aging, while that of the axial skeleton show minimal decrease related to this biologic phenomenon. These findings are of value in assessing the effects of hematological and other disorders in the distribution and the metabolic activity of this important tissue and testing therapeutic interventions that are employed for treating such maladies.
本研究的目的是通过全身2-脱氧-2-[F-18]氟-D-葡萄糖(FDG)-正电子发射断层扫描(PET)来确定红骨髓在分布及其代谢活性程度方面与年龄相关的变化。
这项回顾性研究纳入了112例患者(男性56例,女性56例,平均年龄40岁,范围2-85岁),这些患者接受了全身FDG-PET扫描,以评估确定不影响红骨髓活性的疾病。这些患者按性别均等分布被分为以下几组:0-15岁(12人)、16-25岁(20人)、26-35岁(10人)、36-45岁(20人)、46-55岁(14人)、56-65岁(16人)、66-75岁(14人)和76-85岁(6人)。在静脉注射0.14 mCi/kg的FDG后60分钟进行全身FDG-PET图像采集。使用专用的全身PET扫描仪。从肱骨和股骨上三分之一、胸骨柄、第12胸椎和第5腰椎以及骨盆的髂前上棘的三个连续横断面上计算最大标准化摄取值(SUV(max))。回顾了这些受试者其他影像学检查[磁共振成像(MRI)、计算机断层扫描(CT)和传统放射学]的所有可用结果、实验室数据、活检以及临床病程,以确保所检查的骨髓部位没有任何已知病变。
四肢的SUV(max)随着年龄增长呈显著下降(相关系数为-0.60至-0.67,p<0.01)。相比之下,轴向骨骼活性与年龄增长的相关性较弱(相关系数为-0.28至-0.48,p<0.05)。
这些数据表明,随着正常衰老,四肢红骨髓的FDG代谢活性显著下降,而轴向骨骼的FDG代谢活性与这种生物学现象相关的下降最小。这些发现对于评估血液学和其他疾病对这一重要组织的分布和代谢活性的影响以及测试用于治疗此类疾病的治疗干预措施具有重要价值。